Contact Careers rss

Enterprise Stakeholders

The Global HIV Vaccine Enterprise enables greater collaboration among organizations involved in HIV vaccine research and development by promoting more efficient, faster ways for researchers to share successes and failures and avoid duplication of efforts. The Enterprise calls for complementing current investigator-led efforts with large-scale, well-funded, collaborative efforts across institutions and disciplines, and tackling major scientific problems that have proven too difficult for any one group to tackle alone. In addition, Enterprise stakeholders are also exploring a variety of new approaches to encourage innovation and support high-risk/high-reward ideas to HIV vaccine discovery efforts.

The Enterprise is comprised of organizations and individuals working together to implement a shared Scientific Strategic Plan. These include funding agencies, research organizations, non-government organizations, international agencies, and individual scientists supported by different programs that have been launched or realigned to target the Scientific Strategic Plan research priorities.

Enterprise Stakeholders Include:
  • African AIDS Vaccine Programme (AAVP)
  • AIDS Vaccine Advocacy Coalition (AVAC)
  • AIDS Vaccine Asian Network (AVAN)
  • Bill & Melinda Gates Foundation
  • Canadian HIV Vaccine Initiative (CHVI)
  • Center for HIV/AIDS Vaccine Immunology (CHAVI)
  • Chinese AIDS Vaccine Initiative
  • Collaboration for AIDS Vaccine Discovery (CAVD)
  • Department for International Development (DFID)
  • European Commission
  • Europrise
  • EuroVacc
  • GlaxoSmithKline
  • HIV Vaccine Trials Network (HVTN)
  • International AIDS Vaccine Initiative (IAVI)
  • Merck & Co. Inc.
  • National Agency for AIDS Research (ANRS)
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • Novartis Vaccines
  • sanofi pasteur
  • South African AIDS Vaccine Initiative (SAAVI)
  • U.S. Military HIV Research Program (MHRP)
  • Vaccine Research Center (VRC)
  • The Wellcome Trust
  • World Health Organization (WHO)

Global HIV Vaccine Enterprise, 200 Park Ave. S. Suite 1501, New York, NY 10003 | +1 212-461-3692 or toll free at +1-866-966-4483

All Content ©2005 - 2009 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account